Inventor
XING WEIQIANG
CN12 patents
⚠️ This page may combine multiple inventors who share the name “XING WEIQIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GASHERBRUM BIO INC
4 patentsUS11926626B2Mar 12, 2024
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC7 citations84
US12221442B2Feb 11, 2025
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC3 citations73
US11926643B2Mar 12, 2024
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC0 citations61
US12595264B2Apr 7, 2026
Heterocyclic GLP-1 agonists
GASHERBRUM BIO INC0 citations50
SHANGHAI JEMINCARE PHARMACEUTICALS CO LTD
4 patentsUS11767312B2Sep 26, 2023
Phthalazinone compound, and preparation method therefor and medical use thereof
SHANGHAI JEMINCARE PHARMACEUTICALS CO LTD6 citations80
US12195457B2Jan 14, 2025
Aromatic ring derivative as immunoregulation and preparation method and application of aromatic ring derivative
SHANGHAI JEMINCARE PHARMACEUTICALS CO LTD2 citations70
US12234223B2Feb 25, 2025
Phthalazinone compound, and preparation method therefor and medical use thereof
SHANGHAI JEMINCARE PHARMACEUTICALS CO LTD0 citations57
US12441706B2Oct 14, 2025
Protein degradation agent compound preparation method and application
SHANGHAI JEMINCARE PHARMACEUTICALS CO LTD0 citations47
GLAXOSMITHKLINE IP DEV LTD
3 patentsUS10975081B2Apr 13, 2021
Substituted fused pyrazole compounds and their use as LRRK2 inhibitors
GLAXOSMITHKLINE IP DEV LTD1 citations61
US11034696B2Jun 15, 2021
Compounds for inhibiting LRRK2 kinase activity
GLAXOSMITHKLINE IP DEV LTD1 citations59
US10858367B2Dec 8, 2020
Compounds
GLAXOSMITHKLINE IP DEV LTD0 citations39